{"version":"1.0","provider_name":"Leitat Technological Center","provider_url":"https:\/\/leitat.org\/en\/","author_name":"Dissemination Manager","author_url":"https:\/\/leitat.org\/en\/blog\/author\/editor-wp\/","title":"HPK1-INHIB Project: Innovation in Cancer Immunotherapy - Leitat Technological Center","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"cuk2pxA4d0\"><a href=\"https:\/\/leitat.org\/en\/blog\/hpk1-inhib-project-innovation-in-cancer-immunotherapy\/\">HPK1-INHIB Project: Innovation in Cancer Immunotherapy<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/leitat.org\/en\/blog\/hpk1-inhib-project-innovation-in-cancer-immunotherapy\/embed\/#?secret=cuk2pxA4d0\" width=\"600\" height=\"338\" title=\"&#8220;HPK1-INHIB Project: Innovation in Cancer Immunotherapy&#8221; &#8212; Leitat Technological Center\" data-secret=\"cuk2pxA4d0\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/leitat.org\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/leitat.org\/wp-content\/uploads\/2025\/09\/Texto-3.png","thumbnail_width":1200,"thumbnail_height":700,"description":"Cancer immunotherapy, also known as immuno-oncology, represents one of the greatest revolutions in cancer treatment in recent decades. This therapeutic strategy uses the patient\u2019s own immune system to prevent, control, and eliminate tumors, offering more specific and less toxic alternatives than traditional treatments. Among the multiple modalities of immunotherapy are targeted antibodies, cancer vaccines, adoptive [&hellip;]"}